References
- King H, Aubert R, Herman W. Global burden of diabetes 1995–2025. Diabetes Care 1998; 21: 1414–1431
- Pedersen K K, Hagen C, Sando-Pedersen S H, Eshoj O. Infertility and pregnancy outcome in women with insulin-dependent diabetes. An epidemiological study. Ugeskr Laeger 1994; 156: 6196–6200
- Evers I M, de Valk H W, Visser G H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 2004; 328: 915
- Ray J R, O'Brien T E, Chan W S. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001; 94: 435–444
- Duijkers I, Killick S, Bigrigg A, Dieben T OM. A comparative study on the effects of contraceptive vaginal ring NuvaRing® and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function. Eur J Contracept Reprod Health Care 2004; 9: 131–140
- Magnusdóttir E M, Bjarnadóttir R I, Onundarson P T, Gudmundsdóttir B R, Geirsson R T, Magnusdóttir S D, Dieben T O. The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study. Contraception 2004; 69: 461–467
- Tuppurainen M, Klimscheffskij R, Venhola M, Dieben T OM. The combined contraceptive vaginal ring (NuvaRing®) and lipid metabolism: a comparative study. Contraception 2004; 69: 389–394
- Beckman J A, Creager M A, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc 2002; 287: 2570–2581
- Garg S K, Chase H P, Marshall G, Hoops S L, Holmes D L, Jackson W E. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. J Am Med Assoc 1994; 271: 1099–1102
- Milsom I, Lete I, Bjertnaes A, Rokstad K, Lindh I, Gruber C J, Birkhäuser M H, Aubeny E, Knudsen T, Bastianelli C. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 μg ethinyl estradiol and 3 mg drospirenone. Hum Reprod 2006; 21: 2304–2311
- Lobo R A, Skinner J B, Lippman J S, Cirillo S J. Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis. Fertil Steril 1996; 65: 1100–1109
- Sitruk-Ware R, Plu-Bureau G, Menard J, Conard J, Kumar S, Thalabard J C, Tokay B, Bouchard P. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, cross-over study. J Clin Endocrinol Metab 2007; 92: 2074–2079
- Donders G G. Lower genital tract infections in diabetic women. Curr Infect Dis Rep 2002; 4: 536–539
- Davies G C, Feng L X, Newton J R, Dieben T O, Coelingh-Bennink H J. The effects of a combined contraceptive vaginal ring releasing ethinyl oestradiol and 3-ketodesogestrel on vaginal flora. Contraception 1992; 45: 511–518